In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The new online Learning Center with new content can still be found under the “Training” folder on ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...